Clindamycin Hydrochloride
Product Images NDC 61919-441

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Clindamycin Hydrochloride (NDC 61919-441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct Rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

441 (441 30)

CLINDAMYCIN HYDROCHLORIDE 300 mg 30 Capsules bottle label by DIRECT RX. The label highlights clindamycin hydrochloride as the active ingredient, with each capsule containing 300 mg equivalent. It specifies generic for CLEOCIN and includes storage and usage instructions along with lot and expiration date areas. The label also shows the NDC 61919-441-30 and is marked as packaged and distributed by DIRECT RX in Alpharetta, GA.*

FDA Label Image

Image Description (Module 1)

Chemical structure of clindamycin hydrochloride, showing its molecular formula C18H33ClN2O5S with hydrochloride (HCl). The image includes the chemical name methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside monohydrochloride.*

FDA Label Image

Image Description (Table 1)

A table titled 'Acceptable Quality Control Ranges for Clindamycin to be Used in Validation of Susceptibility Test Results' lists quality control ranges for minimum inhibitory concentrations and disk diffusion zone diameters in millimeters for various aerobic and anaerobic bacterial strains, including Staphylococcus aureus, Streptococcus pneumoniae, Bacteroides fragilis, Bacteroides thetaiotaomicron, and Eubacterium lentum. Notes indicate 'NA' means not applicable and reference ATCC as a registered trademark of the American Type Culture Collection.*

FDA Label Image

Image Description (Table 2)

A data table titled 'Table 1. Susceptibility Interpretive Criteria for Clindamycin' showing susceptibility interpretive criteria by pathogen. It lists minimal inhibitory concentrations (MIC in mcg/mL) with susceptible (S), intermediate (I), and resistant (R) breakpoints, as well as disk diffusion zone diameters in millimeters for Staphylococcus spp., Streptococcus pneumoniae and other Streptococcus spp., and Anaerobic Bacteria. Note that 'NA' indicates not applicable for some disk diffusion criteria.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.